Detalles de la búsqueda
1.
Chemotherapy or allogeneic transplantation in high-risk Philadelphia chromosome-negative adult lymphoblastic leukemia.
Blood
; 137(14): 1879-1894, 2021 04 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33150388
2.
Axicabtagene ciloleucel compared to tisagenlecleucel for the treatment of aggressive B-cell lymphoma.
Haematologica
; 108(1): 110-121, 2023 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35770532
3.
Clinical course and risk factors for mortality from COVID-19 in patients with haematological malignancies.
Eur J Haematol
; 105(5): 597-607, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32710500
4.
COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA.
Blood
; 139(10): 1588-1592, 2022 03 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34748627
5.
Increased survival due to lower toxicity for high-risk T-cell acute lymphoblastic leukemia patients in two consecutive pediatric-inspired PETHEMA trials.
Eur J Haematol
; 102(1): 79-86, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30267597
6.
Use of eltrombopag after romiplostim in primary immune thrombocytopenia.
Br J Haematol
; 169(1): 111-6, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25521630
7.
Interobserver variance in myelodysplastic syndromes with less than 5 % bone marrow blasts: unilineage vs. multilineage dysplasia and reproducibility of the threshold of 2 % blasts.
Ann Hematol
; 94(4): 565-73, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25387664
8.
Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopenia.
Am J Hematol
; 90(3): E40-3, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25400215
9.
Sustained response after discontinuation of short-and medium-term treatment with eltrombopag in patients with immune thrombocytopenia.
Platelets
; 26(1): 83-6, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-24499036
10.
Financial toxicity in allogeneic haematopoietic stem cell transplant patients from a social determinants of health perspective.
Eur J Oncol Nurs
; 70: 102584, 2024 Apr 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38631123
11.
The mortality of COVID-19 in CML patients from 2020 until 2022: results from the EPICOVIDEHA survey.
Leuk Lymphoma
; 65(2): 199-208, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37966980
12.
Clinical Outcomes of Patients with Multiple Myeloma after Daratumumab Failure.
Life (Basel)
; 13(9)2023 Aug 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-37763245
13.
Real-life disease monitoring in follicular lymphoma patients using liquid biopsy ultra-deep sequencing and PET/CT.
Leukemia
; 37(3): 659-669, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36596983
14.
Results of haploidentical transplant in patients with donor-specific antibodies: a survey on behalf of the Spanish Group of Hematopoietic Transplant and Cell Therapy.
Front Immunol
; 14: 1165759, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37304258
15.
Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients.
Front Immunol
; 14: 1188818, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37342332
16.
Corrigendum: Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients.
Front Immunol
; 14: 1243241, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37662957
17.
Corrigendum: Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients.
Front Immunol
; 14: 1349296, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38268917
18.
COVID-19 Severity and Survival over Time in Patients with Hematologic Malignancies: A Population-Based Registry Study.
Cancers (Basel)
; 15(5)2023 Feb 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-36900296
19.
Impact of SARS-CoV-2 vaccination and monoclonal antibodies on outcome post-CD19-directed CAR T-cell therapy: an EPICOVIDEHA survey.
Blood Adv
; 7(11): 2645-2655, 2023 06 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-37058479
20.
Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe. A matched-paired analysis from the EPICOVIDEHA registry.
Int J Antimicrob Agents
; 62(4): 106952, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37582478